跳至主要内容
临床试验/NCT00498784
NCT00498784已完成4 期

A Multicenter, Open Labelled, Uncontrolled, Phase IV Clinical Study to Evaluate the Health-related Quality of Life and Sexual Well-being in Young (18-35) Healthy Mirena Users Switching From OC, Over the First Year Post-insertion.

Bayer0 个研究点目标入组 141 人开始时间: 2005年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Bayer
入组人数
141
主要终点
Health-related QoL score

研究概览

简要总结

The purpose of this study is to evaluate the changes in the quality of life, as well as in the sexual activity, in women inserted with MIRENA, a hormonal contraceptive intra-uterine system, over the first 12 months of use. Patients switching from oral contraception to an intrauterine contraceptive device (here: MIRENA) will be observed in the first year post MIRENA insertion.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy woman willing to, or having to switch from her OC to another contraceptive method

排除标准

  • Any contraindication to Mirena insertion/use

研究组 & 干预措施

Arm 1

Experimental

干预措施: Mirena (Drug)

结局指标

主要结局

Health-related QoL score

时间窗: 1 year

次要结局

  • Sexuality Index, treatment satisfaction, usual safety outcomes(1 year)

研究者

发起方
Bayer
申办方类型
Industry

相似试验